| Oct 25 |
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
|
| Oct 24 |
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
|
| Oct 21 |
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
|
| Oct 21 |
Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?
|
| Oct 19 |
We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Easily Afford To Drive Business Growth
|
| Oct 19 |
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
|
| Oct 16 |
Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds?
|
| Oct 16 |
Why I Keep Buying These 14 Incredible Growth Stocks
|
| Oct 15 |
CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors
|
| Oct 12 |
2 Biotech Stocks That Are Screaming Buys This Month
|
